AC
ADGM

Armistice Capital’s Adagio Medical Holdings ADGM Stock Holding History

Armistice Capital’s Portfolio ADGM Stock Details ADGM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-478,000
Closed -$497K – 457
2025
Q4 		$497K Buy
+478,000
New +$567K 0.01% 212

Other funds holding ADGM

PA
Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return
SCM
Sio Capital Management New York $604M AUM 96.57% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return
ACM
ADAR1 Capital Management Austin, Texas $2.19B AUM 374.99% 1-Year Est. Return
Alyeska Investment Group
Alyeska Investment Group Chicago, Illinois $38.9B AUM 28.51% 1-Year Est. Return
SCM
Silverarc Capital Management Boston, Massachusetts $962M AUM 524.64% 1-Year Est. Return
SCM
Shaolin Capital Management Miami, Florida $2.1B AUM 64.05% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
AAA
Affinity Asset Advisors New York $2.21B AUM 431.26% 1-Year Est. Return
Vanguard Fiduciary Trust
Vanguard Fiduciary Trust Malvern, Pennsylvania $454B AUM

Armistice Capital's ADGM Position: Q1 2026 in Review

Armistice Capital sold out of Adagio Medical Holdings (ADGM) in Q1 2026, closing a stake of 478,000 shares — an estimated $497K sold.

Armistice Capital first reported a position in ADGM in Q4 2025 and held it in 1 quarter. The position peaked at $497K in Q4 2025. 23 funds tracked by Wall St. Rank hold ADGM as of Q1 2026.

  • Armistice Capital reported no remaining Adagio Medical Holdings position as of Q1 2026 after selling out during the quarter.
  • Armistice Capital sold 478,000 Adagio Medical Holdings shares in Q1 2026, an estimated $497K.
  • Armistice Capital first reported a position in Adagio Medical Holdings in Q4 2025 and held it in 1 quarter.
  • Armistice Capital's Adagio Medical Holdings position peaked at $497K in Q4 2025.
  • 23 funds tracked by Wall St. Rank held Adagio Medical Holdings as of Q1 2026.

Based on Armistice Capital's 13F filing for Q1 2026, filed 15 May 2026.